Ohr Pharmaceutical Inc (OHRP) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 151 transactions totaling $1.1M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Apr 10, 2017 involved a purchase of 171,429 shares valued at $120.0K.
No significant insider buying has been recorded for OHRP in the recent period.
No significant insider selling has been recorded for OHRP in the recent period.
Based on recent SEC filings, insider sentiment for OHRP is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Ohr Pharmaceutical Inc (OHRP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading OHRP stock, having executed 151 transactions in the past 90 days. The most active insider is Orin Hirschman (Executive), who has made 4 transactions totaling $705.2K.
Get notified when executives and directors at OHRP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 10, 2017 | Hirschman Orin | Executive | Purchase | 171,429 | $0.70 | $120.0K | |
| Apr 10, 2017 | Hirschman Orin | Executive | Purchase | 142,858 | $0.70 | $100.0K | |
| Apr 10, 2017 | Backenroth Samuel | Executive | Purchase | 71,429 | $0.70 | $50.0K | |
| Apr 10, 2017 | Scott Slakter Jason | Executive | Purchase | 142,858 | $0.70 | $100.0K | |
| Jul 18, 2016 | Scott Slakter Jason | Executive | Other | 497,859 | $N/A | $0 | |
| Jun 20, 2016 | Backenroth Samuel | Executive | Purchase | 10 | $2.89 | $29 | |
| Jun 20, 2016 | Backenroth Samuel | Executive | Purchase | 8 | $2.88 | $23 | |
| Jun 20, 2016 | Backenroth Samuel | Executive | Purchase | 450 | $2.87 | $1.3K | |
| Jun 20, 2016 | Backenroth Samuel | Executive | Purchase | 1,800 | $2.84 | $5.1K | |
| Jun 20, 2016 | Backenroth Samuel | Executive | Purchase | 200 | $2.71 | $542 | |
| Jun 20, 2016 | Scott Slakter Jason | Executive | Purchase | 550 | $2.71 | $1.5K | |
| Jun 20, 2016 | Scott Slakter Jason | Executive | Purchase | 1,700 | $2.89 | $4.9K | |
| Jun 20, 2016 | Scott Slakter Jason | Executive | Purchase | 85 | $2.88 | $245 | |
| Jun 20, 2016 | Scott Slakter Jason | Executive | Purchase | 1,019 | $2.87 | $2.9K | |
| Jun 20, 2016 | Scott Slakter Jason | Executive | Purchase | 5,431 | $2.84 | $15.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 142 | $1.1M | 64.5% |
Conversion(C) | 2 | $526.6K | 30.3% |
Exercise (Options)(X) | 1 | $90.2K | 5.2% |
Other(J) | 3 | $0 | 0.0% |
Award(A) | 2 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at Ohr Pharmaceutical Inc are accumulating shares at an accelerated pace. With 7 insiders making 151 transactions totaling $1.1M in purchases versus $0 in sales, the net buying activity of $1.1M signals strong executive confidence. Orin Hirschman (Executive) leads the buying activity with $705.2K in transactions across all time.